MS Speaks

Multiple Sclerosis => TREATMENTS => OCREVUS (ocrelizumab) => Topic started by: agate on April 28, 2017, 10:16:05 am

Title: Link to NEJM correspondence re Ocrevus (ocrelizumab)
Post by: agate on April 28, 2017, 10:16:05 am

The April 27  issue of the New England Journal of Medicine contains several letters and an authors' reply about  recent articles in NEJM about ocrelizumab in  primary progressive and relapsing multiple sclerosis.

The correspondence can be seen here (http://www.nejm.org/doi/full/10.1056/NEJMc1702076?query=TOC).